Want to see MOTS full AI Analyst Report?
MOTS Stock Chart & Stats
$0.03
$0.00(0.00%)
At close: 4:00 PM EST
$0.03
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $10.06
Previous CloseN/A
Volume44.00
Average Volume (3M)14.62K
Market Cap
$6.00
Enterprise Value-$2.49M
Total Cash (Recent Filing)$4.94M
Total Debt (Recent Filing)$2.44M
Price to Earnings (P/E)―
Beta348.04
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,388,876
10 Day Avg. Volume14,621
30 Day Avg. Volume14,621
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.02
Price to Sales (P/S)0.16
P/FCF Ratio>-0.01
Enterprise Value/Market Cap-414.89K
Enterprise Value/Revenue-7.61
Enterprise Value/Gross Profit15.56
Enterprise Value/Ebitda0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Innovative Product OfferingThe Pure-Vu System enhances the efficacy of colonoscopies, potentially reducing the need for repeat procedures. This innovation can drive adoption in hospitals and clinics, supporting long-term revenue growth as the product addresses a critical need in gastrointestinal endoscopy.
Strategic PartnershipsStrategic partnerships can enhance market penetration and adoption of the Pure-Vu System. Collaborations with healthcare providers can lead to increased sales and potentially open new revenue streams, strengthening the company's market position over time.
Operational Cost ManagementImproved cost management indicates the company's efforts to enhance operational efficiency. This can lead to better financial performance in the long term, as cost controls may eventually translate into improved margins and reduced losses.
Bears Say
Declining Revenue TrendA declining revenue trend poses a significant challenge, indicating reduced market demand or competitive pressures. This trend can strain financial resources and limit growth opportunities, impacting the company's ability to invest in new initiatives or expand its market presence.
Negative Cash FlowsNegative cash flows highlight ongoing liquidity challenges and reliance on external funding. This situation can limit the company's ability to invest in growth initiatives and may necessitate further financing, increasing financial risk and potentially diluting shareholder value.
Consistent Net LossesPersistent net losses indicate operational inefficiencies and challenges in achieving profitability. This ongoing financial instability can undermine investor confidence and limit the company's ability to attract new capital, hindering long-term growth and sustainability.
Motus Gi Holdings News
MOTS FAQ
What was Motus Gi Holdings Inc’s price range in the past 12 months?
Motus Gi Holdings Inc lowest stock price was <$0.01 and its highest was $10.06 in the past 12 months.
What is Motus Gi Holdings Inc’s market cap?
Motus Gi Holdings Inc’s market cap is $6.00.
When is Motus Gi Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Motus Gi Holdings Inc’s earnings last quarter?
Currently, no data Available
Is Motus Gi Holdings Inc overvalued?
According to Wall Street analysts Motus Gi Holdings Inc’s price is currently Overvalued.
Does Motus Gi Holdings Inc pay dividends?
Motus Gi Holdings Inc does not currently pay dividends.
What is Motus Gi Holdings Inc’s EPS estimate?
Motus Gi Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Motus Gi Holdings Inc have?
Motus Gi Holdings Inc has 6,388,876 shares outstanding.
What happened to Motus Gi Holdings Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Motus Gi Holdings Inc?
Currently, no hedge funds are holding shares in MOTS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Motus Gi Holdings Inc
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Ownership Overview
―
Insiders
―
Mutual Funds
4.88% Other Institutional Investors
95.12% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---